- Home
- VIGL vs FNGR Comparison
VIGL vs FNGR Comparison
Compare VIGL & FNGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIGL
- FNGR
- Stock Information
- Founded
- VIGL 2020
- FNGR 2016
- Country
- VIGL United States
- FNGR Singapore
- Employees
- VIGL N/A
- FNGR N/A
- Industry
- VIGL Biotechnology: Pharmaceutical Preparations
- FNGR Computer Software: Prepackaged Software
- Sector
- VIGL Health Care
- FNGR Technology
- Exchange
- VIGL Nasdaq
- FNGR Nasdaq
- Market Cap
- VIGL 134.9M
- FNGR 113.4M
- IPO Year
- VIGL 2022
- FNGR N/A
- Fundamental
- Price
- VIGL $8.05
- FNGR $1.96
- Analyst Decision
- VIGL Buy
- FNGR
- Analyst Count
- VIGL 7
- FNGR 0
- Target Price
- VIGL $8.00
- FNGR N/A
- AVG Volume (30 Days)
- VIGL 1.1M
- FNGR 297.5K
- Earning Date
- VIGL 08-12-2025
- FNGR 07-22-2025
- Dividend Yield
- VIGL N/A
- FNGR N/A
- EPS Growth
- VIGL N/A
- FNGR N/A
- EPS
- VIGL N/A
- FNGR N/A
- Revenue
- VIGL N/A
- FNGR $35,607,614.00
- Revenue This Year
- VIGL N/A
- FNGR N/A
- Revenue Next Year
- VIGL N/A
- FNGR N/A
- P/E Ratio
- VIGL N/A
- FNGR N/A
- Revenue Growth
- VIGL N/A
- FNGR N/A
- 52 Week Low
- VIGL $1.31
- FNGR $1.03
- 52 Week High
- VIGL $8.06
- FNGR $5.20
- Technical
- Relative Strength Index (RSI)
- VIGL 88.18
- FNGR 35.99
- Support Level
- VIGL $7.86
- FNGR $1.94
- Resistance Level
- VIGL $8.05
- FNGR $2.01
- Average True Range (ATR)
- VIGL 0.02
- FNGR 0.10
- MACD
- VIGL -0.15
- FNGR 0.02
- Stochastic Oscillator
- VIGL 73.15
- FNGR 10.53
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.
About FNGR FingerMotion Inc.
FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company business line includes Telecommunications Products and Services; Value Added Products and Services; Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Big Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.